Candelaria Serrano Redonnet

Candelaria Serrano Redonnet currently serves as a Clinical Study Excellence Scientist at Bayer, focusing on the CSES FIND-CKD and FIONA Trials since February 2025. Concurrently, Candelaria holds the position of Scientific Technical Advisor and Clinical Trial Manager for the SARA Clinical Trial at the Barcelona Institute for Global Health (ISGlobal), which investigates the efficacy and safety of low doses of Acetylsalicylic Acid in pregnant women infected with SARS-COV2 across multiple centers in Spain and Mozambique. Previous roles include Project Evaluator for the VHIR Ethics Committee, Clinical Coordinator for the International Committee of the Red Cross, and Medical Doctor at various institutions including Elma, Banc de Sang i Teixits, and Fleni. Candelaria is highly educated with degrees in Clinical Research and International Health, alongside a specialization in Pediatrics and a foundational medical degree, all obtained from notable universities in Spain and Argentina.